Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
dna
2
×
achromatopsia
antibodies
beta-thalassemia
bill cassidy
bluebird bio
boston blog main
boston top stories
clinical trials
deals
extreme
fda
gene therapy
harvard pilgrim health care
health
hemophilia
hiv
johnson & johnson
life sciences
luxturna
mark warner
mathai mammen
medicaid
medicine
meiragtx
national blog main
national top stories
new york
new york blog main
new york top stories
novartis
patient affordability value and efficiency act
spark therapeutics
spinal muscular atrophy
university of pennsylvania
value based agreements
viruses
x-linked retinitis pigmentosa
zolgensma
What
come
2
×
past
age
antibodies
bigger
biggest
cures
deal
different
emerging
exactly
gave
gene
gone
good
hiv
j
johnson
mean
means
meiragtx
morning
new
research
signal
signals
spot
target
therapy
vaccines
weak
years
Language
Current search:
come
×
dna
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@extremetech.com
8 years ago
What it means to find a “weak spot” in HIV